Results 241 to 250 of about 483,678 (300)

Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction‐associated steatotic liver disease treated with semaglutide: A case series

JPGN Reports, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) affects 30%–40% of youth with obesity and lacks approved pharmacologic therapies. In this single‐center retrospective case series at a tertiary care safety‐net children's hospital, we evaluated five adolescents (mean age: 17.0 years; 100% Hispanic; 60% male; mean body mass index:
Rachel Schenker, Katya Fomenko, Fotini T. Mitsinikos, Alaina P. Vidmar   +3 more
wiley   +1 more source

Chronic blood-borne viral hepatitis in a tertiary hospital in Al-Baha, Saudi Arabia: epidemiology, liver enzyme correlations, and treatment outcomes. [PDF]

BMC Infect Dis
Sallam TA, El-Badry RM, Alkully TH, Alfahemi HH, Halwani MA, Alzahrani KI, Alghamdi MA.   +6 more
europepmc   +1 more source

Association of CD33 genetic variants with neurocognitive profiles in chronic viral hepatitis. [PDF]

BJPsych Open
Tsai WF, Yu RL, Chuang WL, Huang JF, Dai CY, Huang YA, Tan CH.   +6 more
europepmc   +1 more source

Updates in viral hepatitis in 2024 - summary of education, research and leadership activities of the ESCMID Study Group for Viral Hepatitis (ESGVH). [PDF]

Germs
Săndulescu O, Hasanoğlu İ, Matičič M.   +2 more
europepmc   +1 more source

Impact of Distributing Test Result Reports for Chronic Viral Hepatitis on Awareness of Hepatitis Testing Among Non-Specialist Physicians. [PDF]

Medicina (Kaunas)
Itakura J, Ito Y, Suzuki T, Aoki Y, Takamura K, Yajima K, Miyahara R, Uetake H, Otomo Y.   +8 more
europepmc   +1 more source